What is Ayvakit (avapritinib), and what is it used for? Brand name: Ayvakit Generic: avapritinib Ayvakit is a prescription medicine used to treat adults with a certain type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumor (GIST) that cannot be treated with surgery or that has spread to other parts of the body (metastatic), and …
Read More »cancer
How Long Can You Live With Waldenstrom’s? Survival Rate Chart
The International Waldenstrom's Macroglobulinemia Foundation finds that half of the people diagnosed with this cancer have a survival rate of 14 to 16 years. The five-year survival rate of Waldenstrom’s macroglobulinemia is about 78 percent, which means that 78 percent of people diagnosed with the condition lived for at least five years after their diagnosis. The survival rate of any …
Read More »What Does a Lymphoma Skin Rash Look Like? Stages & Treatment
Lymphoma skin rashes may be itchy and appear as red or purple with dry scales. Learn about skin lymphoma symptoms and treatment Lymphoma skin rashes may be itchy and appear as red or purple with dry scales, especially along the skin folds. Irritation may sometimes occur with or without rash. Rashes appear as different types of lesions on the skin: …
Read More »What Is the Survival Rate for Follicular Lymphoma?
The five-year survival rate for follicular lymphoma is 80-90% with patients surviving for a median of 10-12 years. Patients with stage I follicular lymphoma may be cured with radiation therapy. The five-year survival rate for follicular lymphoma is between 80 and 90 percent, which means at least 80 to 90 percent of patients diagnosed with follicular lymphoma can live for …
Read More »What Is B-Cell Acute Lymphoblastic Leukemia (B-cell ALL)?
B-cell acute lymphoblastic leukemia (B-cell ALL) is a type of blood cancer that affects B lymphocytes, which are white blood cells found in the bone marrow that develop into cells and aid in immunity. B-cell acute lymphoblastic leukemia (B-cell ALL) is a type of blood cancer (leukemia) in which too many B-cell lymphoblasts (immature B lymphocytes) are found in the …
Read More »Is Non-Small Cell Lung Cancer Aggressive? NSCLC Lifespan
NSCLC is slow-growing and less aggressive than SCLC, which means the survival rate and lifespan are better compared to other types of lung cancer. Lung cancer is one of the deadliest forms of cancer with many deaths that surpass the three most common cancers combined (colon, breast and pancreatic). There are two main types of lung cancer based on the …
Read More »SCLC vs. NSCLC: Which Lung Cancer Type is More Aggressive?
While NSCLC is the more common type of lung cancer, it is slow-growing and far less aggressive than SCLC. Non-small cell lung cancer (NSCLC) carries a better prognosis than small cell lung cancer (SCLC). NSCLC is slow-growing, whereas SCLC grows far more aggressively. Additionally, NSCLC is the more common type, accounting for 85 percent of cases, whereas SCLC is rarer, …
Read More »Stage III Lung Cancer Lifespan & Survival Rate
The lifespan and survival rate of patients diagnosed with stage III lung cancer depends on the type and subtype of the cancerous tumor. Typically, there are four stages for any cancer progression, with each stage representing the extent or spread, number and size of the tumor in the body. After identifying the stage, doctors decide the right treatment and can …
Read More »Stage IV Cancer Lifespan & Survival Rate: Is There a Cure?
While stage IV lung cancer is hard to cure, advancements in cancer treatments may help improve your lifespan and survival rate, depending on your overall state of health. Your doctor is the best person to talk to when it comes to your cancer diagnosis and outlook. Fortunately, cancer research has grown rapidly in the last few years, and the lifespan …
Read More »What Is the Survival Rate for Stage I Lung Cancer?
Typically, the survival rate for stage I lung cancer is anywhere from 70 to 92 percent, depending on the type. Early diagnosis and treatment can improve the outlook. Lung cancer, the third most common type of cancer, is the leading cause of cancer-related deaths worldwide. Though it can be fatal, early diagnosis and treatment can improve the outlook. However, survival …
Read More »